Axon Enterprise NASDAQ: AXON expects its expanded investment in drone maker Skydio to strengthen its public safety product ecosystem, while growth in software and AI helps offset delayed federal deals and higher component costs, Chief Financial Officer and Chief Operating Officer Brittany Bagley said.
Speaking at an investor event, Bagley said Axon increased its ownership in Skydio to about 37% and secured exclusive distribution rights for the drone maker’s public safety products in the U.S. and Canada. The event’s interviewer described the transaction as a $1.2 billion investment.
Bagley said the ownership stake more than doubled, adding roughly 20 percentage points, and gives Axon greater alignment with a partner whose products it plans to sell through its customer channels. Rather than acquire Skydio outright, Axon chose a partnership that allows the drone company to continue developing its own roadmap and serving other markets, she said.
Axon also changed the transaction’s payment structure after filing an 8-K, shifting from a mix of cash and stock to approximately 90% cash. Bagley said Axon did not want to issue equity at its recent share price. A small equity component will go directly to Skydio, giving each company an ownership interest in the other, she said.
Software Growth and Delayed Drone Deals
Bagley said Axon’s product portfolio now spans 911 call handling, real-time information through Fusus, devices such as body cameras and TASERs, and drone dispatch through Skydio. AI products, including body-camera translation, are intended to make interactions and video more useful, she said.
The interviewer noted that Axon’s AI products had surpassed $100 million in annual recurring revenue. Bagley said newer software categories, including Fusus, Dedrone software, 911 and AI, had reached $500 million in annual recurring revenue.
She cited Draft One and Translation as popular products and said Axon Assistant is newer. Longer-term customer contracts mean some agencies may add AI products during their existing agreements, while others may wait until renewals over the next five or more years, she said.
Bagley also addressed three large Dedrone deals totaling about $130 million that the interviewer said had been delayed. She said Axon expects the federal deals it had anticipated in the third and fourth quarters to arrive later, hopefully in 2027, though timing remains partly outside the company’s control.
Even without those deals, Axon expects approximately 30% growth for the year, Bagley said. She added that the Platform Solutions segment, which includes Dedrone, grew more than 100% in the quarter.
Device Upgrades and Margin Pressures
In Axon’s established device business, Bagley said TASER 10 grew in the third quarter and the AB4 body camera grew about 25%, although older products grew more slowly. Axon expects the transition from AB4 to the newly announced AB5 in the second or third quarter of next year, she said.
Bagley also pointed to corrections, federal and international customers as opportunities beyond Axon’s core state and local market. The newly announced TASER Ion is a smaller device designed for people such as undercover officers who cannot openly carry a TASER on a duty belt, she said.
On margins, Bagley said higher memory costs are expected to have an approximately 50-basis-point impact this year, mostly in the fourth quarter. Software growth should help offset some of that pressure, while operating expense leverage can help protect adjusted EBITDA margins, she said.
Axon has not issued guidance for next year, but Bagley said adjusted EBITDA margins approximately flat with this year would be a reasonable expectation. She also said core software margins remain above 80%, while the broader software and services line could remain in the mid-70% range as newer products require installation and other professional services.
Cash Flow and New Markets
Bagley said Axon hopes to reach a normalized inventory level by the first half of 2027. She agreed that free cash flow conversion in 2027 could fall between the approximately 40% target cited by the interviewer for 2026 and the 60% goal for 2028. Delayed Dedrone revenue also contributed to lower-than-expected free cash flow this year, she said.
In newer markets, Bagley said early feedback on the Axon Body Mini has been positive among retail and healthcare customers, though moving from trials to broad deployment could take time. She also described automatic license plate readers as a long-term growth opportunity, while acknowledging community concerns about how the data is collected and used.
Bagley said Axon sees continued opportunity in both its software and core businesses. “There is no reason to assume we cannot keep going in that mid-20s at least kind of growth rate for the long term,” she said.
About Axon Enterprise (NASDAQ:AXON)
Axon Enterprise develops technology and services for public safety agencies. Its products include TASER conducted-energy weapons, body-worn and in-car cameras, and related hardware designed to support law enforcement and other safety professionals. The company also provides cloud-based software for managing digital evidence, records and operational workflows. Its Axon Evidence platform helps agencies store, organize and share video and other evidence, while its broader software offerings include tools for dispatch and records management.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Axon Enterprise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.
While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.
This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.